Investigație imagistică avansată, disponibilă acum și în România

The PET-CT PSMA investigation plays a crucial role in diagnosing and staging prostate cancer by providing detailed information about the disease's location and extent. Previously limited in Romania due to advanced technology requirements, this examination is now available at SANADOR Oncology Center. It utilizes a radiotracer that binds to PSMA-expressing cells, allowing for the identification of positive lesions. The test is particularly useful in complex cases and for staging high-risk prostate cancer. The indication for PET-CT PSMA is determined by the physician based on clinical context, and it is not a routine examination for all patients. Access to this investigation enables more accurate evaluations and tailored therapeutic plans for patients.